MLCL — Molecule Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Molecule Holdings, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

	2018 October 31st	2019 October 31st	2020 October 31st	2021 October 31st	2022 October 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.019	0.005	1.14	1.2	0.084
Net Total Accounts Receivable
Net Total Receivables	0.008	0.009	0.103	0.391	0.283
Total Inventory
Prepaid Expenses
Total Current Assets	0.028	0.014	1.53	2.71	1.28
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.73	0	3.92	3.25	2.63
Long Term Investments
Total Assets	3.76	0.978	5.45	5.96	3.91
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.334	0.473	1.14	4.35	7.52
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.334	0.473	2.01	5.32	7.61
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	3.43	0.505	3.44	0.638	-3.69
Total Liabilities & Shareholders' Equity	3.76	0.978	5.45	5.96	3.91
Total Common Shares Outstanding